CHU de Quebec-Universite Laval
2 clinical trials · 2 recruiting · OTHER
Trials by CHU de Quebec-Universite Laval
RECRUITINGPhase 2NCT05327647
A Phase II Trial of Bicalutamide in Patients Receiving Intravesical BCG for Non-muscle Invasive Bladder Cancer
This is a phase II randomized controlled clinical trial comparing standard induction BCG versus bicalutamide and standard induction BCG among patients with non-muscle invasive...
Sponsor: CHU de Quebec-Universite LavalEnrolling: 1607 locations
Non-Muscle Invasive Bladder Cancer
RECRUITINGNCT07067827
Self-questionnaire in Osteoporosis
Osteoporosis is a multifactorial disease in which genetic predispositions play a key role in its development. A better understanding of family history and clinical manifestations...
Sponsor: CHU de Quebec-Universite LavalEnrolling: 581 location
Osteoporosis